Literature DB >> 17448957

Risk assessment in haematopoietic stem cell transplantation: viral status.

Per Ljungman1.   

Abstract

Viral infections have been important complications in the transplant procedure from the early days of stem-cell transplantation, causing significant morbidity and mortality. It is important for the management of patients to assess the risk for viral infections that might develop after the stem-cell transplantation. This can be exemplified by cytomegalovirus (CMV) and other herpesviruses, but risk assessment is also important for other viral infections. The aim of this review is to describe current knowledge regarding recipient and donor serological status for viral infections.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17448957     DOI： 10.1016/j.beha.2006.09.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN： 1521-6926            Impact factor:   3.020


  11 in total

1.  Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation.

Authors:  Mikael Sundin; Anna Lindblom; Claes Örvell; A John Barrett; Berit Sundberg; Emma Watz; Agneta Wikman; Kristina Broliden; Katarina Le Blanc
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

Review 2.  Immunosuppressive properties of mesenchymal stem cells.

Authors:  Mohamed Abumaree; Mohammed Al Jumah; Rishika A Pace; Bill Kalionis
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

Review 3.  Immunobiology of human cytomegalovirus: from bench to bedside.

Authors:  Tania Crough; Rajiv Khanna
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

4.  Donor and recipient CMV serostatus and outcome of pediatric allogeneic HSCT for acute leukemia in the era of CMV-preemptive therapy.

Authors:  Carolyn E Behrendt; Joseph Rosenthal; Ellen Bolotin; Ryotaro Nakamura; John Zaia; Stephen J Forman
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

5.  Humoral and cellular CMV responses in healthy donors; identification of a frequent population of CMV-specific, CD4+ T cells in seronegative donors.

Authors:  Nina Loeth; Kristian Assing; Hans O Madsen; Lars Vindeløv; Soren Buus; Anette Stryhn
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

6.  CMV Serostatus of Donor-Recipient Pairs Influences the Risk of CMV Infection/Reactivation in HSCT Patients.

Authors:  Emilia Jaskula; Jolanta Bochenska; Edyta Kocwin; Agnieszka Tarnowska; Andrzej Lange
Journal:  Bone Marrow Res       Date:  2012-11-22

7.  Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.

Authors:  Thomas Widmann; Urban Sester; Barbara C Gärtner; Jörg Schubert; Michael Pfreundschuh; Hans Köhler; Martina Sester
Journal:  PLoS One       Date:  2008-11-04       Impact factor: 3.240

8.  Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection.

Authors:  Simone Avanzi; Valerio Leoni; Antonella Rotola; Francesco Alviano; Liliana Solimando; Giacomo Lanzoni; Laura Bonsi; Dario Di Luca; Cosetta Marchionni; Gualtiero Alvisi; Alessandro Ripalti
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Investigation of epstein-barr virus and parvovirus b19 DNA in allogeneic stem cell transplant patients.

Authors:  Altay Atalay; Selma Gökahmetoğlu; Süleyman Durmaz; Idris Kandemir; Derya Sağlam; Leylagül Kaynar; Bülent Eser; Mustafa Cetin; Hüseyin Kılıç
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

Review 10.  Hematopoietic cell transplantation and emerging viral infections.

Authors:  D Chatzidimitriou; E Gavriilaki; I Sakellari; E Diza
Journal:  J Med Virol       Date:  2010-03       Impact factor: 2.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.